Acenxion Biosytems, Inc. — Form D
Acenxion Biosytems, Inc. of LAWRENCE, KS, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-18. The offering totals $2.0M, of which $50K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-18
- Form: D
- Accession: 0001974107-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $50K
- Remaining: $2.0M
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2023-04-01
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-479135
Issuer
- Name: Acenxion Biosytems, Inc.
- CIK: 0001974107
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 2029 BECKER DRIVE, LAWRENCE, KS, 66047
- Phone: 3217490523
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Howard Goldstein | Director | Aquinnah, MA |
| Brian Struchtemeyer | Director | Lawrence, KS |
| Brian Struchtemeyer | Executive Officer | Lawrence, KS |
| Roy Swiger | Director | Lawrence, KS |
| Roy Swiger | Executive Officer | Lawrence, KS |
| Wayne Carter | Director | Lawrence, KS |
Other filings by this issuer (1)
More